Best Cyber Insurance for Clinical Research Organizations (CROs)

Pre-revenue and early-stage CROs ($0-$5M revenue): $1M-$3M cyber tower is typical. Below $1M is hard to defend at sponsor MSA review; above $3M is hard to justify at early-stage premium budget.

Mid-market CROs ($5M-$20M revenue): $3M-$10M tower. The exact placement depends on the largest sponsor cyber demand in active CTAs and the number of patient records under active management.

Established CROs ($20M-$100M revenue): $10M-$25M tower. Multi-site international operations typically need country-specific local policies layered onto the master program.

HIPAA Business Associate coverage: The cyber form should explicitly cover defense costs, settlements, and regulatory penalties arising from Business Associate Agreement obligations. Standard cyber forms increasingly include this, but verify the specific language addresses civil monetary penalties under HITECH.

Regulatory defense for state privacy laws: Coverage should address Washington MHMDA, Connecticut Data Privacy Act, Maryland MOPDPA, Texas TDPSA, CCPA/CPRA, and any state where clinical trial sites are located. The 2026 regulatory landscape requires multi-state attestation.

Dependent business interruption: Loss of revenue arising from a sponsor or site cyber event, not just the CRO's own systems. Increasingly demanded by CTA wording.

Voluntary notification: Coverage for proactive customer notification when no statutory notice is required. The reputational cost of withheld notification often exceeds the cost of overnotification.

Forensic IR retainer: Pre-selected incident response firm on retainer with hours included. Reduces the time from incident discovery to active investigation from days to hours.

Sponsor additional insured for vendor cyber: Many sponsor MSAs now require the CRO's cyber policy to add the sponsor as additional insured for cyber claims arising from the CRO's data handling.

Cyber premium for a CRO is set mainly by the number of patient records under management, the number of active CTAs and the cyber limits they require, the maturity of security controls (MFA on remote access, EDR, immutable backups, a tested incident response plan), international trial sites, and prior loss history, especially any ransomware event.

Underwriters tend to credit documented controls: SOC 2 Type II or ISO 27001 certification, round-the-clock security monitoring, and a clean claims record. Missing MFA or a recent ransomware loss can narrow the market and raise retentions as much as it raises price.

Because these factors interact, a published range would mislead more CROs than it helps. A coverage review prices the tower against your actual records, contracts, and controls.

Operator-side advisory cannot recommend specific carriers by name (per Texas Department of Insurance advertising-rule compliance and brand-neutral positioning). What we can do is identify the structural elements that distinguish strong CRO cyber programs from weak ones at the same premium. The most common gap we see at first review: lack of dependent business interruption coverage despite sponsor MSAs requiring it, and lack of state-by-state regulatory defense coverage despite multi-state clinical trial activity.

The right cyber program for a CRO is the one that satisfies the largest sponsor CTA cyber demand in the active book plus the state regulatory regime of every active trial site plus the HIPAA Business Associate floor. The wrong program is one that meets a generic professional services cyber template without addressing the CRO-specific exposures.